[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Hospital Samaritano Paulista\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":38},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":5},"100496288","aspire-aub-has2-plus-biomarkers-100496288",false,"NCT05742282","ASPIRE (Aub-haS2 Plus bIomaRkErs)","Validation of the AUB-HAS2 Score in a Brazilian Population and Study of the Additional Impact of Biomarkers in Predicting Perioperative Risk","ASPIRE","Inclusion Criteria:\n\n* Age ≥ 40 years, in the preoperative period of non-cardiac procedures, with expected hospitalization for at least 24 hours postoperatively.\n\nExclusion Criteria:\n\n* Refusal to sign the informed consent form.","ALL","40 Years",{"count":20,"type":21},2500,"ESTIMATED","OBSERVATIONAL","ASPIRE is a prospective, multicenter, observational study that will assess the performance of AUB-HAS2 to predict the occurrence of major adverse cardiovascular events 30-days after a non-cardiac surgery and the additional role of high-sensitivity troponin T and NT-ProBNP biomarkers in the accuracy of different event prediction indexes after non-cardiac procedures.",[25],"Perioperative Medicine","NOT_YET_RECRUITING","2025-05-15",{"date":29,"type":30},"2025-05-20","ACTUAL",{"date":32,"type":21},"2025-06-21",{"date":34,"type":21},"2026-10-30",{"name":36,"class":37},"Hospital Samaritano Paulista","OTHER",""]